Searched for
DRUG PRICE EXEMPTION
Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
- Vijay sworn in as Tamil Nadu CM: Here's what TVK promised ahead of Assembly pollsTamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...
- Donald Trump's drugmaker deals may save economy $529 billion over 10 years: White HousePresident Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...
- Why is the 2026 Social Security 2.8% COLA failing against 3.3% inflation? Is your retirement check shrinking?Social Security COLA 2026 Inflation Gap: Why 2.8% Increase Trails 3.3% Senior Inflation. The 2.8% Social Security COLA for 2026 is failing....
- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- India largely shielded from US tariffs on patented drugs due to generic export strength: GTRINew US tariffs on patented drugs will not significantly impact India. The country mainly exports affordable generic medicines to America. T...
- Tariff therapy: Trump nudges pharma cos to make drugs in US or face 100% tariffAmerica is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...
- Sun Pharma most exposed Indian company to Trump's new tariff threat, warns JefferiesIndian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...
- Budget 2025: 'Customs waiver on life-saving drugs won't benefit most patients'Despite the import duty waiver on life-saving drugs for rare diseases announced in the union budget, patients might not benefit due to high...
- NPPA ropes in patent office to decide on pleas for price cap exemptionIndia's drug pricing regulator, NPPA, is increasing scrutiny of pharmaceutical companies seeking price exemptions. The NPPA is collaboratin...
- GST exemption on medicines for rare diseases is unlikely to provide any relief to those in need: Health activistsThe recent GST exemption on medicines for rare diseases in India is unlikely to help many patients as the drugs are still too expensive, sa...
- Centre plans on tweaking drug policy that exempts foreign medicines from price controlThe government broadened the five-year exemption from price control for new foreign drugs patented in India through an amendment in January...
- NPPA seeks clarification on Gilead's drug pricing pleaNational Pharmaceutical Pricing Authority has sought clarifications from the company. Gilead had sought exemption from price control for it...
- SC pulls up Ranbaxy on late refund demandThe Supreme Court has admonished Ranbaxy for not raising on the relevant occasion the issue of refunding Rs 1 crore penalty the government ...
- SC gives clean chit to Ranbaxy on ECA 'violation'In a major relief to drug major Ranbaxy Laboratories, the Supreme Court on Monday held that the company did not violate any law by selling ...
- Ministry may impose temporary freeze on scheduled drug pricesThe prices of medicines are set to undergo a major change once the new national drug policy is notified, depending on the formula the gover...
Load More
